share_log

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director NEUGEBOREN EDWARD

SEC ·  Dec 20, 2023 13:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more